Tetrahedral Framework Nucleic Acids Reestablish Immune Tolerance and Restore Saliva Secretion in a Sjögren’s Syndrome Mouse Model
Shaojingya Gao,Yun Wang,Yanjing Li,Dexuan Xiao,Yunfeng Lin,Yu Chen,Xiaoxiao Cai
DOI: https://doi.org/10.1021/acsami.1c14861
2021-09-03
Abstract:As one of the most frequent autoimmune diseases, Sjogren's syndrome (SS) is characterized by overactive lymphocytic infiltration in the exocrine glands, with ensuing dry mouth and dry eyes. Unfortunately, so far, there are no appropriate therapies without causing overall immunosuppression. Tetrahedral framework nucleic acids (tFNAs) were regarded as promising nanoscale materials whose immunomodulatory capabilities have already been verified. Herein, we reveal, for the first time, that tFNAs were utilized to treat SS in female nonobese diabetic (NOD) mice, the animal model used for SS. We proved a 250 nM tFNA treatment was successful in suppressing inflammation and stimulating saliva secretion in NOD mice. Specialised proteins for the secretory function and structure of acinar cells in submandibular glands (SMGs) were restored. It has been the permanent goal for SS treatment to establish immune tolerance and stop disease development. Surprisingly, tFNA treatment guided T cells toward regulatory T cells (Tregs), while suppressing T helper (Th) cell responses. Th cells include Th1, Th17, and follicular helper T (Tfh) cells. Tregs are highly significant in immune tolerance. Inducing Tregs is a promising approach to reestablish immune tolerance. Comparable results were also observed in B cell responses. Reductions in the percentage of germinal center (GC) B cells and plasma cells were detected, and a marked increase in the percentage of regulatory B cells (Bregs) was also noticed. The mechanisms of inducing Tregs may associated with cytokine changes. Changes of T cell subsets, especially changes of Tfh, may influence the differentiation of B cells accordingly. Collectively, our results demonstrated the immunomodulatory capacities of tFNAs once again, which may provide a novel, safe, and effective option for the treatment of SS and other autoimmune diseases.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c14861.Figure S1, AFM image of tFNAs; Figure S2, blood cytokine concentration at the end point of the experiment; Figure S3–S5, representative immunofluorescence images of SMGs; Figure S6–S7, representative flow cytometry pattern and quantitative analyses of CD4+ T cell subsets; Figure S8, quantitative analysis of Th2 in SMGs; Figures S9 and S10, representative flow cytometry pattern and quantitative analyses of B cell subsets; Figure S11, representative histological images of heart, liver, lung, and kidney (PDF)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology